[1] [1] HORNING K J, CAITO S W, TIPPS K G, et al. Manganese is essential for neuronal health［J］. Annu Rev Nutr, 2015, 35(1): 71-108.

[2] [2] BOTAR R, MOLNAR E, TRENCSENYI G, et al. Stable and inert Mn(II)-based and pH-responsive contrast agents［J］. J Am Chem Soc, 2020, 142(4): 1662-1666.

[3] [3] DING B B, ZHENG P, JIANG F, et al. MnOx nanospikes as nanoadjuvants and immunogenic cell death drugs with enhanced antitumor immunity and antimetastatic effect［J］. Angew Chem Int Ed, 2020, 59(38): 16381-16384.

[4] [4] XIANG Y, LI N L, GUO L J, et al. Biocompatible and pH-sensitive MnO-loaded carbonaceous nanospheres (MnO@CNSs): A theranostic agent for magnetic resonance imaging-guided photothermal therapy［J］. Carbon, 2018, 136: 113-124.

[5] [5] VERONIAINA H, WU Z, QI X. Innate tumor-targeted nanozyme overcoming tumor hypoxia for cancer theranostic use［J］. J Adv Res, 2021, 33: 201-213.

[6] [6] JAIN P, PATEL K, JANGID A K, et al. Biotinylated Mn3O4 nanocuboids for targeted delivery of gemcitabine hydrochloride to breast cancer and MRI applications［J］. Int J Pharm, 2021, 606: 120895.

[7] [7] YANG X Y, ZHOU Z G, WANG L, et al. Folate conjugated Mn3O4@SiO2 nanoparticles for targeted magnetic resonance imaging in vivo［J］. Mater Res Bull, 2014, 57: 97-102.

[8] [8] LIN L S, SONG J, SONG L, et al. Simultaneous Fenton-like ion delivery and glutathione depletion by MnO2-based nanoagent to enhance chemodynamic therapy［J］. Angew Chem Int Ed, 2018, 57(18): 4902-4906.

[9] [9] LU C, ZHANG C, WANG P, et al. Light-free generation of singlet oxygen through manganese-thiophene nanosystems for pH-responsive chemiluminescence imaging and tumor therapy［J］. Chem, 2020, 6(9): 2314-2334.

[10] [10] CHEN Y, CHEN H R, ZHANG S J, et al. Structure-property relationships in manganese oxide-mesoporous silica nanoparticles used for T1-weighted MRI and simultaneous anti-cancer drug delivery［J］. Biomaterials, 2012, 33(7): 2388-2398.

[11] [11] LI X W, ZHAO W R, LIU X H, et al. Mesoporous manganese silicate coated silica nanoparticles as multi-stimuli-responsive T1-MRI contrast agents and drug delivery carriers［J］. Acta Biomater, 2016, 30: 378-387.

[12] [12] ZHANG J Y, JIN M S, PARK Y I, et al. Facile synthesis of ultra-small hollow manganese silicate nanoparticles as pH/GSH-responsive T1-MRI contrast agents［J］. Ceram Int, 2020, 46(11): 18632-18638.

[13] [13] NAFIUJJAMAN M, CHUNG S-J, KALASHNIKOVA I, et al. Biodegradable hollow manganese silicate nanocomposites to alleviate tumor hypoxia toward enhanced photodynamic therapy［J］. ACS Appl Bio Mater, 2020, 3(11): 7989-7999.

[14] [14] ZHU D, ZHU X H, REN S Z, et al. Manganese dioxide (MnO2) based nanomaterials for cancer therapies and theranostics［J］. J Drug Target, 2021, 29(9): 911-924.

[15] [15] WANG H J, BREMNER D H, WU K H, et al. Platelet membrane biomimetic bufalin-loaded hollow MnO2 nanoparticles for MRI-guided chemo-chemodynamic combined therapy of cancer［J］. Chem Eng J, 2020, 382: 122848.

[16] [16] MURALI A, LOKHANDE G, DEO K A, et al. Emerging 2D nanomaterials for biomedical applications［J］. Mater Today, 2021, 50: 276-302.

[19] [19] LI X W, ZHAO W R, LIU Y J, et al. Facile synthesis of manganese silicate nanoparticles for pH/GSH-responsive T1-weighted magnetic resonance imaging［J］. J Mater Chem B, 2016, 4(24): 4313-4321.

[20] [20] PALMAI M, PETHO A, NAGY L N, et al. Direct immobilization of manganese chelates on silica nanospheres for MRI applications［J］. J Colloid Interf Sci, 2017, 498: 298-305.

[22] [22] CHEN Y, YIN Q, JI X, et al. Manganese oxide-based multifunctionalized mesoporous silica nanoparticles for pH-responsive MRI, ultrasonography and circumvention of MDR in cancer cells［J］. Biomaterials, 2012, 33(29): 7126-7137.

[23] [23] LIU C H, CAO Y, CHENG Y, et al. An open source and reduce expenditure ROS generation strategy for chemodynamic/photodynamic synergistic therapy［J］. Nat Commun, 2020, 11(1): 1735.

[24] [24] ZHANG K, XU L L, JIANG J G, et al. Facile large-scale synthesis of monodisperse mesoporous silica nanospheres with tunable pore structure［J］. J Am Chem Soc, 2013, 135(7): 2427-2430.

[25] [25] WU J F, QIN C, MA J G, et al. An immunomodulatory bioink with hollow manganese silicate nanospheres for angiogenesis［J］. Appl Mater Today, 2021, 23: 101015.

[26] [26] YU L D, CHEN Y, WU M Y, et al. “Manganese extraction” strategy enables yumor-sensitive biodegradability and theranostics of nanoparticles［J］. J Am Chem Soc, 2016, 138(31): 9881-9894.

[27] [27] MA H, YU Q, QU Y, et al. Manganese silicate nanospheres-incorporated hydrogels: starvation therapy and tissue regeneration［J］. Bioact Mater, 2021, 6(12): 4558-4567.

[28] [28] WANG S, LI F, QIAO R, et al. Arginine-rich manganese silicate nanobubbles as a ferroptosis-inducing agent for tumor-targeted theranostics［J］. ACS Nano, 2018, 12(12): 12380-12392.

[29] [29] QUAN B, CHOI K, KIM Y H, et al. Near infrared dye indocyanine green doped silica nanoparticles for biological imaging［J］. Talanta, 2012, 99: 387-393.

[30] [30] QUAN B, LEE C, YOO J S, et al. Facile scalable synthesis of highly monodisperse small silica nanoparticles using alkaline buffer solution and their application for efficient sentinel lymph node mapping［J］. J Mater Chem B, 2017, 5(3): 586-594.

[31] [31] YU S-H, QUAN B, JIN A H, et al. Hollow nanostructured metal silicates with tunable properties for lithium ion battery anodes［J］. ACS Appl Mater Interfaces, 2015, 7(46): 25725-25732.

[32] [32] QUAN B, JIN A, YU S H, et al. Solvothermal-derived S-doped graphene as an anode material for sodium-ion batteries［J］. Adv Sci, 2018, 5(5): 1700880.

[33] [33] CHEN Z H, KIM C, ZENG X B, et al. Characterizing size and porosity of hollow nanoparticles: SAXS, SANS, TEM, DLS, and adsorption isotherms compared［J］. Langmuir, 2012, 28(43): 15350-15361.

[34] [34] KIM J G, JANG M S, KUMARI N, et al. Differential characterization of hepatic tumors in MR imaging by burst-released Mn2+-ions from hollow manganese-silicate nanoparticles in the liver［J］. Biomaterials, 2020, 230: 119600.

[35] [35] KIM J G, KIM S M, LEE I S. Mechanistic Insight into the Yolk@Shell transformation of MnO@Silica nanospheres incorporating Ni2+ ions toward a colloidal hollow nanoreactor［J］. Small, 2015, 11(16): 1930-1938.

[36] [36] CHEN J, ZHANG W J, GUO Z, et al. pH-responsive iron manganese silicate nanoparticles as T1-T2* dual-modal imaging probes for tumor diagnosis［J］. ACS Appl Mater Interfaces, 2015, 7(9): 5373-5383.

[37] [37] XU J, SHI R, CHEN G, et al. All-in-one theranostic nanomedicine with ultrabright second near-infrared emission for tumor-modulated bioimaging and chemodynamic/photodynamic therapy［J］. ACS Nano, 2020, 14(8): 9613-9625.

[39] [39] YEC C C, ZENG H C. Nanobubbles within a microbubble: Synthesis and self-assembly of hollow manganese silicate and its metal-doped derivatives［J］. ACS Nano, 2014, 8(6): 6407-6416.

[40] [40] FENG L L, HE F, DAI Y L, et al. Multifunctional UCNPs@MnSiO3@g-C3N4 nanoplatform: improved ROS generation and reduced glutathione levels for highly efficient photodynamic therapy［J］. Biomater Sci, 2017, 5(12): 2456-2467.

[41] [41] XI J, HUANG Y, CHEN J, et al. Artesunate-loaded poly (lactic-co-glycolic acid)/polydopamine-manganese oxides nanoparticles as an oxidase mimic for tumor chemo-catalytic therapy［J］. Int J Biol Macromol, 2021, 181: 72-81.

[42] [42] XIE C, CEN D, WANG H, et al. Hierarchical nanoclusters with programmed disassembly for mitochondria-targeted tumor therapy with MR imaging［J］. Biomater Sci, 2021, 9(24): 8189-8201.

[43] [43] SUN K, HU J, MENG X, et al. Reinforcing the induction of immunogenic cell death via artificial engineered cascade bioreactor-enhanced chemo-immunotherapy for optimizing cancer immunotherapy［J］. Small, 2021, 17(37): 2101897.

[44] [44] DU W X, LIU T Z, XUE F F, et al. Confined nanoparticles growth within hollow mesoporous nanoreactors for highly efficient MRI-guided photodynamic therapy［J］. Chem Eng J, 2020, 379: 122251.

[46] [46] LIU C, WANG D, ZHANG S, et al. Biodegradable biomimic copper/manganese silicate nanospheres for chemodynamic/ photodynamic synergistic therapy with simultaneous glutathione depletion and hypoxia relief［J］. ACS Nano, 2019, 13(4): 4267-4277.